Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01708512 · ClinicalTrials.gov registry record · NA
Feasibility Study: Higher Density Ulthera® System Treatment With Vectoring for Treatment of the Face and Neck
A NA study, sponsored by Ulthera.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT01708512 is a NA study that has completed, run by Ulthera. The registered enrollment target is 21 participants.
The verdict
NCT01708512, a NA study, has completed, sponsored by Ulthera.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
All enrolled subject will receive one Ultherapy™ treatment. Study images will be obtained pre-treatment, immediate post-treatment, and at each study follow-up visit. Enrolled subjects will return for follow-up visits at 90 days, 180 days and 365 days post-treatment.
Interventions
- DEVICE Ulthera System Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2012-04 |
| Est. Completion | 2013-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01708512
The ClinicalTrials.gov registry entry for NCT01708512 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ulthera, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ulthera System Treatment is the first listed.
NCT01708512 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01708512 about?
NCT01708512 is a clinical study titled "Feasibility Study: Higher Density Ulthera® System Treatment With Vectoring for Treatment of the Face and Neck". All enrolled subject will receive one Ultherapy™ treatment. Study images will be obtained pre-treatment, immediate post-treatment, and at each study follow-up visit. Enrolled subjects will return for follow-up visits at 90 days, 180 days and 365 days post-treatment.
What is the current status of trial NCT01708512?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2012-04. Estimated completion is 2013-07.
What interventions are being tested in trial NCT01708512?
The interventions under investigation include: Ulthera System Treatment (DEVICE).
Who is sponsoring clinical trial NCT01708512?
This trial is sponsored by Ulthera, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.